Epigenetic modulation with oral histone deacetylase (HDAC) inhibitor as a new treatment option in JIA
Saved in:
Main Authors: | Damjanov N (Author), Furlan A (Author), Vojinovic J (Author), D'Urzo C (Author), Dinarello CA (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2011-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
by: Ehab Ghazy, et al.
Published: (2022) -
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs.
by: Hugo Rolando Vaca, et al.
Published: (2021) -
Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors
by: María Galán, et al.
Published: (2016) -
Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs
by: Wang Y, et al.
Published: (2017) -
Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors
by: Beatriz Silva Urias, et al.
Published: (2022)